Within Subject Variability Study of ER Torsemide 20 mg Tablet in Healthy Subjects
Clinical trial NCT03214874 · COMPLETED
Trial details
- NCT number
- NCT03214874
- Sponsor
- Sarfez Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-19
- Primary completion
- 2017-07-20
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.